IN185781B - - Google Patents

Info

Publication number
IN185781B
IN185781B IN1286DE1996A IN185781B IN 185781 B IN185781 B IN 185781B IN 1286DE1996 A IN1286DE1996 A IN 1286DE1996A IN 185781 B IN185781 B IN 185781B
Authority
IN
India
Prior art keywords
alkyl
pct
formula
group
compounds
Prior art date
Application number
Other languages
English (en)
Inventor
Laszlo Urogdi
Ede Marvanyos
Mi Haly Barabas
Laszlo Jaszlits
Katalin Biro
Andrea Jednakovits
Original Assignee
Biorex Kutato Fejlesztoe Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kutato Fejlesztoe Kft filed Critical Biorex Kutato Fejlesztoe Kft
Publication of IN185781B publication Critical patent/IN185781B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
IN1286DE1996 1995-06-15 1996-06-12 IN185781B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9501756A HU218480B (hu) 1995-06-15 1995-06-15 Hidroxilaminszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények

Publications (1)

Publication Number Publication Date
IN185781B true IN185781B (de) 2001-04-28

Family

ID=10986948

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1286DE1996 IN185781B (de) 1995-06-15 1996-06-12

Country Status (23)

Country Link
US (1) US6002002A (de)
EP (1) EP0832079B1 (de)
JP (1) JP4083800B2 (de)
KR (1) KR100444780B1 (de)
AT (1) ATE215075T1 (de)
AU (1) AU703163B2 (de)
BR (1) BR9608929A (de)
CA (1) CA2221689C (de)
CZ (1) CZ295547B6 (de)
DE (1) DE69620175T2 (de)
DK (1) DK0832079T3 (de)
ES (1) ES2174077T3 (de)
HR (1) HRP960279B1 (de)
HU (1) HU218480B (de)
IL (1) IL122141A (de)
IN (1) IN185781B (de)
PL (1) PL185592B1 (de)
PT (1) PT832079E (de)
SI (1) SI0832079T1 (de)
SK (1) SK282953B6 (de)
WO (1) WO1997000251A1 (de)
YU (1) YU49419B (de)
ZA (1) ZA964978B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA64716C2 (en) * 1996-08-09 2004-03-15 Pharmaceuticals for therapy or prevention of illnesses connected with dysfunction of vascular endothelial cells
WO2003057664A1 (en) 2002-01-11 2003-07-17 Biorex Kutató És Fejlesztö Rt. Carboxamidine derivatives and their use in the treatment of vascular diseases
WO2005074594A2 (en) 2004-01-30 2005-08-18 Great Lakes Chemical Corporation Production processes and systems, compositions, surfactants, monomer units, metal complexes, phosphate esters, glycols, aqueous film forming foams, and foam stabilizers
US8318656B2 (en) 2007-07-03 2012-11-27 E. I. Du Pont De Nemours And Company Production processes and systems, compositions, surfactants, monomer units, metal complexes, phosphate esters, glycols, aqueous film forming foams, and foam stabilizers
KR101405103B1 (ko) * 2014-03-25 2014-06-10 재 남 우 레버식 수동개방기구를 구비하는 초고압 압축가스 개폐장치

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE369944C (de) * 1918-03-07 1923-02-24 Anilin Fabrikation Ag Verfahren zur Darstellung von Tetrahydronaphthalin
DE2651083A1 (de) * 1976-11-09 1978-05-18 Hoechst Ag Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung
EP0369944A1 (de) * 1988-11-18 1990-05-23 Ciba-Geigy Ag Substituierte Oxadiaminobutane
EP0495750A3 (en) * 1991-01-14 1992-09-16 Ciba-Geigy Ag Heterocyclic hydroxylamine

Also Published As

Publication number Publication date
DK0832079T3 (da) 2002-06-03
US6002002A (en) 1999-12-14
KR100444780B1 (ko) 2004-11-26
ZA964978B (en) 1997-02-24
CZ401597A3 (cs) 1998-04-15
CA2221689A1 (en) 1997-01-03
BR9608929A (pt) 1999-06-15
SK282953B6 (sk) 2003-01-09
HU9501756D0 (en) 1995-08-28
HRP960279A2 (en) 1997-12-31
WO1997000251A1 (en) 1997-01-03
SI0832079T1 (en) 2002-08-31
CA2221689C (en) 2007-08-07
PL324197A1 (en) 1998-05-11
CZ295547B6 (cs) 2005-08-17
MX9710172A (es) 1998-07-31
AU6237696A (en) 1997-01-15
ES2174077T3 (es) 2002-11-01
YU49419B (sh) 2006-01-16
EP0832079A1 (de) 1998-04-01
PL185592B1 (pl) 2003-06-30
AU703163B2 (en) 1999-03-18
KR19990022961A (ko) 1999-03-25
HUT74621A (en) 1997-01-28
IL122141A (en) 2003-07-06
IL122141A0 (en) 1998-04-05
PT832079E (pt) 2002-07-31
JP4083800B2 (ja) 2008-04-30
DE69620175T2 (de) 2002-08-22
JPH11507662A (ja) 1999-07-06
HU218480B (hu) 2000-09-28
YU36996A (sh) 1998-11-05
ATE215075T1 (de) 2002-04-15
HRP960279B1 (en) 2002-02-28
DE69620175D1 (de) 2002-05-02
SK171397A3 (en) 1998-06-03
EP0832079B1 (de) 2002-03-27

Similar Documents

Publication Publication Date Title
ATE128975T1 (de) Harnstoffderivate, verfahren zu ihrer herstellung und diese enthaltende medikamente.
NZ324007A (en) Quinazoline derivatives susbtituted by a phenyl and medicaments
HUT54149A (en) Process for producing new 3-brackets open 4-(1-substituted-4-piperazinyl)-butyl brackets closed-4-thiazolidinone derivatives and pharmaceutical compositions comprising such compounds
IE802612L (en) Bicyclo £2.2.1| heptane derivatives
CA2126465A1 (en) Inhibitor for restenosis after percutaneous coronary arterioplasty
GR3034769T3 (en) Triazole antifungal agents.
ES8401075A1 (es) &#34;procedimiento para preparar espiro (piperidino-oxobenzoxazinas) substituidas en posicion 1 anti-hipertensivas&#34;.
HU9300176D0 (en) Method for producing unsaturated 17beta-substituted 3-carboxy steroides
MY141488A (en) Hydroximic acid derivatives, processes for their preparation, and compositions comprising them
AU703163B2 (en) Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions
EP0335979A4 (en) Thienopyrimidine derivatives
MY124696A (en) Pde iv inhibiting pyridine derivatives.
HU9503807D0 (en) Pyridazinone derivatives with pharmaceutical activity
UA50722C2 (uk) Нітробензаміди, спосіб їх одержання (варіанти), фармацевтична композиція
NZ515278A (en) Halo derivatives of 9-deoxo-9a-aza-9a- homerythromycin A their salts and preparation process
DE69428206D1 (de) Chinolincarbonsäurederivate und ihre salze